KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Total Liabilities (2016 - 2026)

Lam Research has reported Total Liabilities over the past 18 years, most recently at $10.2 billion for Q1 2026.

  • For Q1 2026, Total Liabilities fell 2.39% year-over-year to $10.2 billion; the TTM value through Mar 2026 reached $10.2 billion, down 2.39%, while the annual FY2025 figure was $11.5 billion, 12.53% up from the prior year.
  • Total Liabilities for Q1 2026 was $10.2 billion at Lam Research, down from $11.2 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $11.7 billion in Q3 2025 and troughed at $10.2 billion in Q2 2024.
  • A 5-year average of $10.8 billion and a median of $10.8 billion in 2023 define the central range for Total Liabilities.
  • Biggest five-year swings in Total Liabilities: increased 16.04% in 2022 and later decreased 7.23% in 2023.
  • Year by year, Total Liabilities stood at $10.9 billion in 2022, then dropped by 3.12% to $10.6 billion in 2023, then increased by 4.46% to $11.0 billion in 2024, then increased by 1.94% to $11.2 billion in 2025, then decreased by 9.24% to $10.2 billion in 2026.
  • Business Quant data shows Total Liabilities for LRCX at $10.2 billion in Q1 2026, $11.2 billion in Q4 2025, and $11.7 billion in Q3 2025.